Martha J. Demski, Director at ADMA BIOLOGICS, INC. (ADMA), bought 2,200 shares at $2.29 ($5K) on 2020-09-11, disclosed to the SEC on 2020-09-14.
Open-market purchase of $5k ADMA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CMRX | BUY | 2022-05-17 | $16K | — | Filing → |
| ADMS | SELL | 2021-06-08 | $10K | — | Filing → |
| ADMA | BUY | 2020-08-14 | $6K | — | Filing → |